ReviewCancer chemotherapy and pharmacology2022
Anti-cancer drug combinations approved by US FDA from 2011 to 2021: main design features of clinical trials and role of pharmacokinetics.
Salvador Fudio et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it